Galderma Investigational Site #6261

Wroclaw 51-685

0 studies enrolling now · 1 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis — Completed